Companies operating in the Life Sciences industry (e.g. Pharma, Biotech, Medical Devices, and Clinical Trials/Sup-plies) need to identify and track each container of GMP-critical products, either raw materials or manufactured products.
Standard Microsoft Dynamics 365 for Finance and Supply Chain Management offers the ability to manage and track batch numbers and serial numbers.
Microsoft commissioned Forrester Consulting to conduct a Total Economic Impact™ (TEI) study to examine the potential return on investment (ROI) enterprises may realize by migrating from existing, on-premises deployments of Microsoft Dynamics AX to comparable Microsoft Dynamics 365 apps hosted by Microsoft in the cloud.
The purpose of this study is to provide readers with a framework to evaluate the potential financial impact.
Microsoft commissioned Forrester Consulting to conduct a Total Economic Impact™ (TEI) study and examine the potential return on investment (ROI) enterprises may realize by deploying Dynamics 365.
The purpose of this study is to provide readers with a framework to evaluate the potential financial impact of Dynamics 365 on their organizations.
A lack of integrated, industry-specific solutions and M&A activity has left many companies in Life Sciences saddled with a patchwork of siloed legacy systems cobbled together with custom integrations and disparate business processes.
This fragmented operational and application landscape creates operational inefficiencies and compliance vulnerabilities that expose pharmaceutical manufacturers to regulatory consequences and increased operating costs.
This eBook discusses how sector specific, integrated solutions can help Life Sciences companies improve their market value.